"We just don't have the space for it": Geographies of survival and spatial triage in overdose prevention sites.
Canada
Ethnography
Overdose response
People who use drugs
Qualitative research
Service delivery
Triage
Journal
Health & place
ISSN: 1873-2054
Titre abrégé: Health Place
Pays: England
ID NLM: 9510067
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
11
01
2023
revised:
22
04
2023
accepted:
10
06
2023
pmc-release:
01
09
2024
medline:
25
9
2023
pubmed:
23
6
2023
entrez:
23
6
2023
Statut:
ppublish
Résumé
This study explores the role of Overdose Prevention Sites (OPS) within the geographies of survival of vulnerably housed people who use drugs (PWUD) in Vancouver, British Columbia (BC), Canada. In BC, OPS are low-barrier spaces where people may use drugs under monitoring of trained staff. OPS have been established by people who use drugs, activists, and allied organizations as an emergency measure to prevent overdose deaths. However, OPS have other important uses for PWUD who are vulnerably housed and rely on public spaces for survival. Drawing on two years (2018-2020) of ethnographic fieldwork and interviews with fifty-five people who work at and/or use OPS, we explore how OPS operators negotiated multiple and at times competing uses of service space for everyday survival. Data analysis was guided by critical urban theory to explore the place of OPS within PWUD's geographies of survival, with attention to how different uses of space were negotiated within the context of an illicit drug poisoning crisis and urban control practices that displace and exclude unhoused and vulnerably housed PWUD from the city. We find that OPS accommodated other important potential uses of space for unhoused and vulnerably housed PWUD who relied on public space for survival and were routinely displaced by revanchist urban control strategies. Low-barrier approaches and facility enhancements to OPS improved program accessibility and enabled PWUD to use the sites more broadly to meet survival needs including for mutual-aid, sheltering, and income-generation. However, these secondary uses of OPS presented multiple operational challenges as service volumes increased. We observed processes of 'spatial triage' emerge within sites to manage these challenges, which we characterise as a pragmatic set of rules, procedures, and spatial practices that constrained broader uses of OPS within PWUD's geographies of survival. While spatial triage offered a pragmatic way of prioritizing service delivery to address the most acute survival threats of overdose fatality, these practices had unintended and inequitable impacts on service access. Our findings indicate the need for complementary structural changes as part of overdose responses to reduce the need for spatial triage (i.e., safe, affordable housing and drug decriminalisation) and service innovations to mitigate potential harms (e.g., Expanded drop-in and chill spaces, temporary storage spaces for service user).
Identifiants
pubmed: 37352615
pii: S1353-8292(23)00104-1
doi: 10.1016/j.healthplace.2023.103067
pmc: PMC10589902
mid: NIHMS1911912
pii:
doi:
Substances chimiques
Illicit Drugs
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
103067Subventions
Organisme : NIDA NIH HHS
ID : R01 DA044181
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest None.
Références
Drug Alcohol Depend. 2020 Aug 1;213:108078
pubmed: 32485658
Int J Drug Policy. 2013 Sep;24(5):479-87
pubmed: 23664788
Qual Health Res. 2011 Jun;21(6):743-56
pubmed: 21378259
Ann Emerg Med. 2007 Mar;49(3):275-81
pubmed: 17141139
Am J Public Health. 2020 Jun;110(6):833-835
pubmed: 32298171
Int J Drug Policy. 2008 Feb;19(1):4-10
pubmed: 18226520
Int J Drug Policy. 2019 Nov;73:135-140
pubmed: 31654936
Int J Drug Policy. 2020 Feb;76:102641
pubmed: 31887644
Harm Reduct J. 2017 Oct 24;14(1):70
pubmed: 29065896
Int J Drug Policy. 2019 Nov;73:199-207
pubmed: 31542327
Int J Drug Policy. 2012 Jul;23(4):295-302
pubmed: 22417824
Harm Reduct J. 2004 Aug 26;1(1):8
pubmed: 15333130
Med Anthropol. 2020 Nov-Dec;39(8):751-764
pubmed: 32364811
Int J Drug Policy. 2019 Apr;66:64-72
pubmed: 30708237
Soc Sci Med. 2014 Apr;106:151-8
pubmed: 24561777
Addiction. 2019 Sep;114(9):1602-1613
pubmed: 31166621
JAMA Netw Open. 2022 Jan 4;5(1):e2142685
pubmed: 34994799
Contemp Drug Probl. 2023 Mar;50(1):3-24
pubmed: 36733491
Addiction. 2018 Dec;113(12):2261-2270
pubmed: 30211453
Int J Drug Policy. 2021 Apr;90:103076
pubmed: 33321286
Int J Drug Policy. 2010 May;21(3):255-8
pubmed: 19766474
Addiction. 2006 Oct;101(10):1384-93
pubmed: 16968336
AIDS Behav. 2014 Mar;18(3):473-85
pubmed: 23797831
Am J Public Health. 2022 Apr;112(S2):S151-S158
pubmed: 35262376
Drug Alcohol Depend. 2019 May 1;198:1-6
pubmed: 30856370
Soc Sci Med. 2012 Apr;74(8):1251-60
pubmed: 22385814
J Gen Intern Med. 2022 Nov;37(14):3707-3714
pubmed: 35296981
Int J Drug Policy. 2020 Jun;80:102769
pubmed: 32446183
Soc Sci Med. 2019 Mar;225:60-68
pubmed: 30798157
Med Anthropol Q. 2021 Jun;35(2):209-225
pubmed: 33866590
Health Place. 2015 Sep;35:70-8
pubmed: 26241893
Int J Drug Policy. 2019 Sep;71:169-177
pubmed: 30926217
Soc Sci Med. 2008 Sep;67(5):817-23
pubmed: 18562065
Int J Drug Policy. 2015 Jul;26(7):645-52
pubmed: 25683138
Soc Sci Med. 2021 Feb;270:113631
pubmed: 33418149
Addiction. 2022 Apr;117(4):986-997
pubmed: 34854162
Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350
pubmed: 33965972
J Urban Health. 2015 Dec;92(6):1117-30
pubmed: 26453195